CD8A and ovarian carcinoma: Czystowska-Kuzmicz et al. reported that TEX, containing a metabolic checkpoint molecule ARG1 found in the ascites and plasma of ovarian cancer patients suppressed the proliferation of CD4+ and CD8+ T-cells in vitro and in vivo in ovarian cancer mouse models.